Friday , December 15 2017
Home / Managing Editor, Diabetes in Control (page 35)

Managing Editor, Diabetes in Control

Managing Editor, Diabetes in Control

The Value of the Nitric Oxide Pathway and its Importance in African-American Patients with Heart Failure

Talking to Patients

Studies in heart failure and hypertension have shown that people who identify themselves as black may have a less active renin-angiotensin system and a lower bioavailability of nitric oxide. The A-HeFT study was conducted to determine if a fixed dose of isosorbide dinitrate (ISDN) and hydralazine would provide additional benefit in black patients with heart failure.

Read More »